Prior research has reinforced obesity as a major risk factor for poor outcomes in patients with COVID-19. Now, a study conducted at Cleveland Clinic has shown that bariatric surgery may substantially improve the prognosis for these patients.
After an extensive search for a chief of Cleveland Clinic’s Bariatric and Metabolic Institute, Ali Aminian, MD, was named to the leadership position.
Because of the increased risk for severe COVID-19 associated with obesity, it is more important than ever for physicians to keep a close eye on these patients.
Bariatric surgery patients are at increased risk of nutritional deficiencies that can result in the devastating effects of metabolic bone disease. Endocrinologist Susan Williams, RD, MD, MS, discusses her recommendations for preoperative screening and interventions to normalize nutritional and bone indices prior to surgery.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A new Cleveland Clinic-developed risk calculator helps patients with obesity and Type 2 diabetes understand and discuss with their physician the long-term risks of mortality and cardiovascular and renal morbidity, with and without bariatric surgery, allowing for a more informed treatment decision.
Obesity is a complex condition with many comorbidities. At Cleveland Clinic, bariatric surgeons and endocrinologists collaborate to optimize weight loss outcomes, as well as pre- and postoperative nutrition. In this article, Drs. Ali Aminian and Sangeeta Kashyap discuss their collaboration.
Candidates for ablation for symptomatic atrial fibrillation who have severe obesity should be considered for bariatric surgery prior to ablation, a new study suggests.
A large matched-cohort study in patients with type 2 diabetes and obesity finds that metabolic surgery confers significant improvements in all prespecified events plus marked reductions in weight, HbA1c, and use of diabetes and cardiovascular medications.
The annual conference, which takes place in Cleveland and Baton Rouge, provide clinicians the latest on the science and treatment of obesity and its comorbidities.
New details are helping researchers understand precisely why bariatric surgery is associated with a lower risk of CV diseases and events.